MYC, a central regulator closely involved in driving uncontrolled proliferation in cancers, including hematological malignancies [105], is transcriptionally regulated by NF-κB via direct effects on the promoter of both wild-type and translocated MYC [106,107]. The gene discussed is MYC; the disease is hematologic disorder.